AFib, short for atrial fibrillation, is the most common type of irregular heartbeat. It happens when the upper chambers of the heart fire off chaotic electrical signals instead of beating in a steady, coordinated rhythm. This causes the heart to quiver rather than pump efficiently, which can lead to blood pooling, clot formation, and a significantly higher risk of stroke. About one in three people with AFib don’t even know they have it.
How AFib Disrupts the Heart’s Rhythm
In a healthy heart, a single electrical impulse travels through the upper chambers (the atria) in an orderly wave, telling the muscle to contract and push blood into the lower chambers. In AFib, that orderly signal is replaced by rapid, disorganized electrical activity. The atria may fire 300 to 600 times per minute instead of the normal 60 to 100, though the lower chambers don’t keep up with all of those signals.
This electrical chaos can come from several sources. Sometimes a single spot in the heart fires abnormally fast, like a short circuit. Other times, electrical waves loop back on themselves in circular patterns, creating self-sustaining spirals of activity. Over time, the heart’s structure changes in response to these abnormal signals. The atrial walls thicken, scar tissue forms, and the electrical pathways slow down, all of which make future episodes more likely and harder to stop. Cardiologists sometimes describe this as “AFib begets AFib,” meaning the longer it goes untreated, the more entrenched it becomes.
What AFib Feels Like
The classic symptom is a fluttering or pounding sensation in your chest, often described as your heart “flopping around like a fish.” Beyond that, common symptoms include:
- Fatigue that seems out of proportion to your activity level
- Shortness of breath during tasks that didn’t used to wind you
- Dizziness or lightheadedness, especially when standing
- Exercise intolerance, where your stamina drops noticeably
But roughly one-third of people with AFib feel nothing at all. This “silent” AFib is particularly dangerous because it often goes undetected until a serious complication surfaces. Some people only discover they have it after a stroke or when heart failure develops. That’s one reason routine pulse checks and wearable heart monitors have become increasingly important screening tools.
What Causes It
High blood pressure is the single biggest driver. It’s present in more than 80% of people diagnosed with AFib. When blood pressure stays elevated, the heart has to pump harder, which thickens the walls of the left ventricle. That extra strain backs up into the atria, stretching them out and creating scar tissue that disrupts electrical conduction. Essentially, years of high blood pressure remodel the heart into a structure that’s primed for chaotic electrical activity.
Other conditions that raise your risk include heart failure, prior heart attack, valve disease (particularly involving the mitral valve), obesity, diabetes, sleep apnea, and heavy alcohol use. Age is a major factor on its own. Both high blood pressure and AFib become more common as you get older, and the combination compounds stroke risk dramatically. Thyroid disorders, particularly an overactive thyroid, can also trigger episodes.
How AFib Is Diagnosed
An electrocardiogram (ECG) is the primary test. It records the heart’s electrical activity through sensors placed on your chest and can typically confirm AFib in seconds. The telltale sign is an absence of the normal organized electrical pattern in the upper chambers, replaced by an irregular, jagged baseline.
The challenge is catching it. AFib often comes and goes, so a standard ECG taken during a 10-second office visit may look perfectly normal. When your doctor suspects AFib but can’t catch it in the office, portable monitors bridge the gap. A Holter monitor is a small device you wear for one to two days while going about your normal routine. An event recorder extends that window to up to 30 days, recording only when it detects something abnormal or when you press a button during symptoms. For people with very infrequent episodes, a tiny loop recorder can be implanted just under the skin of the chest and continuously monitors heart rhythm for up to three years.
Consumer smartwatches have added another layer of screening. A clinical validation study of five popular wearable devices found that the Apple Watch 6 and Samsung Galaxy Watch 3 both detected AFib with 85% sensitivity and 75% specificity. The AliveCor KardiaMobile performed similarly at 79% sensitivity and 69% specificity. These devices are useful for flagging potential problems, but a positive alert still needs confirmation with a medical-grade ECG.
Why Stroke Prevention Comes First
When the atria quiver instead of contracting properly, blood can pool and form clots. If a clot breaks free and travels to the brain, it causes a stroke. AFib-related strokes tend to be more severe than other types because the clots that form in the heart are often larger.
For most people with AFib, preventing this clot formation is the top treatment priority. Current guidelines from the American Heart Association recommend direct oral anticoagulants (blood thinners) as first-line therapy over the older drug warfarin. These newer medications don’t require the frequent blood testing that warfarin demands, and they have fewer interactions with food and other drugs. Warfarin is still preferred for people with mechanical heart valves or significant mitral valve disease. Importantly, aspirin alone is not recommended for stroke prevention in AFib. It doesn’t reduce the risk enough to justify its use as a substitute for proper anticoagulation.
Rate Control vs. Rhythm Control
Once stroke prevention is addressed, the next decision is how to manage the irregular rhythm itself. There are two broad strategies, and the right choice depends on your age, symptoms, and overall heart health.
Rate Control
This approach accepts that AFib will continue but uses medications to keep the heart from beating too fast. The goal is a resting heart rate that’s comfortable and sustainable. This strategy tends to work best for people with multiple other health conditions, significant enlargement of the atria, or longstanding AFib that’s unlikely to convert back to a normal rhythm. The medications involved slow the electrical signals passing from the upper to lower chambers.
Rhythm Control
This approach aims to restore and maintain a normal heartbeat. It can involve medications, electrical cardioversion (a brief procedure where a controlled shock resets the heart’s rhythm), or catheter ablation. Current guidelines emphasize starting rhythm control early, particularly for younger patients, those with significant symptoms, and people whose heart failure isn’t improving with rate control alone.
The shift toward early rhythm control reflects newer evidence that keeping the heart in its normal rhythm, rather than just controlling the rate, leads to better long-term outcomes when started soon after diagnosis.
What Catheter Ablation Involves
Catheter ablation has become a mainstream treatment and now carries a first-line recommendation for selected patients. During the procedure, thin wires are threaded through a blood vessel (usually in the groin) up to the heart. The tip of the catheter delivers energy, either heat or freezing cold, to create small scars in the atrial tissue responsible for the erratic signals. The most common target is the area where the pulmonary veins connect to the left atrium, since this is where the rogue electrical impulses most often originate.
Success rates depend on the type of AFib. For paroxysmal AFib (episodes that come and go), a single procedure keeps about 69% of people free from AFib at one year, dropping to around 62% at five years. After a second procedure, roughly 79% remain AFib-free at five years. For persistent AFib, where the irregular rhythm is more constant, results are less favorable with a single procedure (about 51% success at one year) but improve substantially with repeat procedures, reaching around 78% long-term success.
Late recurrence remains a reality. Even after initial success, AFib returns at a rate of roughly 7% per year after the first ablation. Recurrence rates at 10 years are 27% for paroxysmal AFib and 62% for persistent AFib, which is why ongoing monitoring matters even after a successful procedure.
Living With AFib
AFib is a chronic condition for most people, but it’s highly manageable. Beyond medications and procedures, the modifiable risk factors make a real difference. Controlling blood pressure is the most impactful single thing you can do, given that hypertension underlies the structural heart changes that sustain AFib. Losing excess weight, treating sleep apnea, reducing alcohol intake, and staying physically active all reduce the frequency and severity of episodes.
Many people with AFib live full, active lives. The condition doesn’t mean you need to stop exercising or avoid travel. It does mean staying consistent with prescribed blood thinners, monitoring your heart rate, and keeping regular follow-up appointments so your treatment can be adjusted as the condition evolves over time.